Responsable(s)
Directeur - Nicolas LHEUREUX à partir du 01/01/2022 ( nicolas.lheureux@u-bordeaux.fr )
Directeur adjoint - Sylvain CATROS à partir du 01/01/2022 ( sylvain.catros@u-bordeaux.fr )
|
|
Etablissements. |
|
INSERM - Institut national de la sante et de la recherche medicale (U 1026)
(établissement tutelle à
partir de 2011)
|
|
BORDEAUX - Université de Bordeaux (UMR_S 1026)
(établissement tutelle à
partir de 2014)
Etablissement référent
|
Adresse
Université de Bordeaux - INSERM Unité 1026 BioTis - 146 rue Léo Saignat
33076 BORDEAUX CEDEX
|
Contact
courriel : nicolas.lheureux@u-bordeaux.fr
|
| Site web :
http://www.biotis-bordeaux.com
|
| Taille en ETP (sans compter les stagiaires):
entre 10 et 50.
|
Descriptif :
The Laboratory for the Bioengineering of Tissues (BioTis U1026) is a Unité Mixte de Recherche (UMR) that combines individuals from the French National Institute of Health and Medical Research (INSERM) and the Université de Bordeaux. This group has been a national leader in the field of bone and vascular tissue engineering for over 30 years.
The research at BioTis (U1026) spans from the fundamental aspects of cell-cell and cell-matrix interactions, all the way to the development of translational models and their clinical applications in vascular, orthopedic, oral and maxillofacial surgery. This has been made possible by a multidisciplinary team of scientists from the INSERM and the National Center for Scientific Research (CNRS), of research professors from the Université de Bordeaux, of clinicians from the University Hospital Center (CHU), and the many Masters, Ph.D.s and Post-docs in training.
Our research strategy combines 3 complementary approaches: 1) a classic “top-down” tissue engineering approach where whole tissues are produced, 2) an intermediate approach where regenerative starting points are produced, such as a periosteum-like vascularized membranes, that can guide healing in vivo, 3) a “bottom-up” approach where small components can be prepared through the integration of various biofabrication methods. In a few years, we have achieved a level of expertise and global visibility in the field of laser-assisted bioprinting. The recent decision of the INSERM to create an Accélérateur de Recherche Technologique (ART) on Bioprinting at BioTis will expand our expertise in additive and subtractive biofabrication methods in order to be in a position to meet any biofabrication challenge faced by the INSERM community.
|
| Année de création :
2011
|
| Mission de la structure :
Recherche
|
| Mode de gestion de la structure :
Non renseigné.
|
| SIRET de la structure :
18003604800908
|
Classement scientifique ERC
- PE5 : Synthetic Chemistry and Materials : New materials and new synthetic approaches, structure-properties relations, solid state chemistry, molecular architecture, organic chemistry
- LS7 : Prevention, Diagnosis and Treatment of Human Diseases : Medical technologies and tools for prevention, diagnosis and treatment of human diseases, therapeutic approaches and interventions, pharmacology, preventative medicine, epidemiology and public health, digital medicine
- PE8 : Products and Processes Engineering : Product and process design, chemical, civil, environmental, mechanical, vehicle engineering, energy processes and relevant computational methods
- LS3 : Cellular, Developmental and Regenerative Biology : Structure and function of the cell, cell-cell communication, embryogenesis, tissue differentiation, organogenesis, growth, development, evolution of development, organoids, stem cells, regeneration, therapeutic approaches
|
Domaine scientifique
- 5 : Biologie, médecine et santé 2011 0
- 8 : Sciences pour l'ingénieur 2011 0
|
Ecole(s) doctorale(s) de rattachement
Non renseigné
|
Rattachée au(x) programme(s) LOLF suivant(s):
Non renseigné
|
Rattachée au(x) thème(s) de recherche suivant(s):
Non renseigné
|
Liens avec d'autres structures :
Aucun.
|
Site ESR :
Convention de coordination en Nouvelle-Aquitaine, depuis le 17/05/2020
|
Fiche mise à jour par Julie GIRY le 30/03/2023 à 11:53
|
